logo
EXCLUSIVE The areas most at risk of a measles outbreak REVEALED amid slump in MMR vaccination rates

EXCLUSIVE The areas most at risk of a measles outbreak REVEALED amid slump in MMR vaccination rates

Daily Mail​15 hours ago
Nowhere in England is safe from a measles outbreak, experts warned today amid a 'very worrying' slump in MMR vaccination rates.
To stop the extremely contagious disease ripping through communities, 95 per cent of children need both doses of the measles, mumps and rubella jab.
Yet MailOnline can today reveal that not a single authority in the country exceeds this threshold, set by the World Health Organization.
Nationally, England has never met the target, which health bosses admit is needed to 'achieve and maintain measles elimination'.
Of the around 150 upper tier local authorities in England, Cumbria recorded the highest uptake – 94.8 per cent of five–year–olds living there have had both MMR doses.
In pockets of the country, fewer than two–thirds of kids are fully protected against the trio of illnesses, latest NHS figures show.
Hackney (combined with the City of London) logged the lowest rate of uptake with 60.8 per cent in 2023/24, followed by Islington (63.8 per cent) and Westminster (64.3 per cent).
Nationally, the figure stands at 83.9 per cent – the lowest figure in a decade.
This equates to around five children in every classroom.
Doctors blame the rise of anti–vaxx beliefs in the wake of Covid for fuelling the fall in rates.
Busy modern lifestyles and public complacency have also been cited for the crisis, with many adults forgetting that measles is a killer.
Dr David Elliman, a consultant community paediatrician and expert in vaccination at University College London, said: 'The drift downwards in uptake of the vaccine is very worrying.
He said: 'It is important that parents have an opportunity to speak to a well-informed health care professional who has the knowledge and time to answer any questions.
'Too often parents say they are rushed and don't get satisfactory answers to their questions.'
The MMR jab, which offers life-long protection, consists of two doses. In Britain, it's given when a child turns one and then again at three years and four months.
After both doses, 99 per cent of people are protected from measles.
The illness, spread through coughs and sneezes, typically causes flu–like symptoms followed by a rash.
However, measles can trigger fatal health complications if it spreads to the lungs or the brain.
If pregnant women get infected, the virus can cause stillbirth and miscarriage.
One child in a classroom can give the virus to up to nine other unvaccinated children within 15 minutes, making it one of the most infectious diseases worldwide and even more transmissible than Covid.
To achieve 'herd immunity', the WHO states 95 per cent of a population needs to be vaccinated against measles.
This would stop the illness from being able to spread, even among the unvaccinated.
It comes after the death of a child in Liverpool last week from measles.
According to the Sunday Times, which revealed the news, it is understood the child who died was severely ill with measles and other serious health problems.
Health officials in the region said that the number of measles infections being treated at Alder Hey Hospital meant there were likely more infections than officially reported.
Last week, public health officials wrote an open letter to parents in the region, urging them to get their children vaccinated.
How do the MMR vaccines work?
The MMR vaccine is a safe and effective combined vaccine.
It protects against three illnesses: measles, mumps and rubella.
The highly infectious conditions can easily spread between unvaccinated people.
The conditions can lead to serious problems including meningitis, hearing loss and problems during pregnancy.
Two doses of the MMR vaccine provide the best protection against measles, mumps and rubella.
The NHS advises anyone who has not had two doses of the MMR vaccine to ask their GP for a vaccination appointment.
Two doses of the jab protects around 99 per cent of people against measles and rubella, while around 88 per cent of people are protected against mumps.
The MMR jab has been offered to children in Britain since the late 90s.
Uptake collapsed in the late 1990s and early 2000s in the wake of a 1998 discredited study by Andrew Wakefield, which falsely linked the vaccine with autism.
Tens of thousands of parents refused to let medics jab their children due to the bogus paper, published in medical journal The Lancet.
Donald Trump's Health Secretary Robert F Kennedy Jr earlier this year vowed to 'look at vaccines', to determine what was behind spiralling autism rates.
Before his appointment, RFK Jr sparked outrage when he told Fox News in 2023: 'I do believe autism comes from vaccines.' Senator Bernie Sanders has even accused RFK Jr of praising Wakefield for his bogus research.
But in April RFK Jr pulled a major about–face when he said the MMR vaccine was the 'most effective way' to stave off the potentially dangerous virus.
Dr Vanessa Saliba, consultant epidemiologist at the UK Health Security Agency, said: 'The decline of the uptake of childhood vaccinations including MMR in England in the past decade means that many thousands of children are left unprotected with the risk of outbreaks linked to nurseries and schools.
'We are concerned that more measles outbreaks will occur on a larger scale this summer, as families travel to visit friends and family over the holidays, both at home and overseas.
'Two doses of the MMR vaccine offers the best protection against measles and importantly vaccination is also about not spreading the disease to others who may be more vulnerable, such as those who are immunosuppressed and young infants aged under one who have not yet had the vaccine.
'Speaking as a doctor and a mother, I strongly encourage all parents to ensure their children have the best possible protection but also to think about protecting other more vulnerable children.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Almost half of people do not think 10-year plan will boost GP access
Almost half of people do not think 10-year plan will boost GP access

North Wales Chronicle

time19 minutes ago

  • North Wales Chronicle

Almost half of people do not think 10-year plan will boost GP access

More than four in 10 also believe the 10-year plan will make no difference or will not improve waiting times in A&E. However, there is huge support for some of the ideas included in the blueprint, with the overwhelming majority backing the creation of neighbourhood health centres, the expansion of the NHS app and more mental health support in schools and colleges. The 10-year health plan was unveiled by Prime Minister Sir Keir Starmer earlier this month, and set out a series of shifts to bring care much closer to people's homes, reducing the reliance on hospitals and A&E. Key reforms include an enhanced NHS app, giving patients more control over their care, new neighbourhood health centres open six days a week and at least 12 hours a day, and new laws on food and alcohol to prevent ill health. A survey of 1,023 adults in Britain, conducted by Ipsos for the PA news agency, asked people how they think the plan will impact access to healthcare, such as getting a GP appointment, A&E waiting times and waiting times for routine hospital treatment. Some 35% said the plan will have no impact on getting a GP appointment, while 14% believe it will make things harder. This compares with the 29% of people who said they think it will make getting an appointment easier. More than a third (37%) said it will make no difference to waiting times in emergency departments, while almost one in 10 (9%), said they believe it could worsen waiting times, compared with 30% who said it will improve them. Meanwhile, 31% said the plan will have no impact on waiting times for hospital treatment, 11% believe the plan will worsen waiting times and 34% said they think the measures will help. However, a number of proposals outlined in the plan were strongly backed by the public. Some 84% said they supported the creation of a single patient record, while 78% backed the creation of neighbourhood health centres, 73% support the expansion of the NHS app and 72% are in favour of more mental health support in schools and colleges. However, more than a quarter (27%) of people do not support making hospitals fully AI enabled, compared with 44% who would back the move. Almost one in five (18%) said they would not support so-called 'patient power payments', which would allow patients to hold back some of the payment for their care if they are not satisfied, while 42% would support the measure. Some proposals aimed at helping people to lead healthier lives were also strongly supported. A ban on the sale of high-caffeine energy drinks was backed by 78% of people, while 69% back plans to restrict junk food advertising. However, almost one in five (18%) tended to disagree with measures that could see alcoholic drinks labelled with nutritional information, although 57% backed the move. One in four people think the measures included in the plan will make no difference to patients, the poll found. Almost one in 10 (9%) said they think the changes will make things worse, while 35% believe it will improve the health service. A similar proportion, 23%, said the 10-year health plan will make no difference to NHS staff, while 13% said it could make things worse and 33% believe it will have a positive effect. A Department of Health and Social Care spokesperson said: 'We're getting on with the job of delivering for patients, with NHS waiting lists falling by 260,000 since July 2024, delivering more than 4.6 million additional appointments since the general election and recruiting over 1,900 extra GPs to fix the front door of the NHS. 'Backed by an additional £29 billion, our 10-year health plan will seize the opportunities provided by new technology, medicines and innovation to deliver better care for all patients, no matter where they live or how much they earn, and better value for taxpayers. 'It is no surprise the plan is popular with patients, it was the result of the biggest conversation with staff, patients and the public since the formation of the NHS, with more than a quarter of a million contributions.'

Patients sought for new NHS trial for brain cancer after man sees tumour vanish
Patients sought for new NHS trial for brain cancer after man sees tumour vanish

North Wales Chronicle

time19 minutes ago

  • North Wales Chronicle

Patients sought for new NHS trial for brain cancer after man sees tumour vanish

The NHS study will recruit 16 people over an 18-month period and has been set up in memory of Baroness Margaret McDonagh, who died of the disease. People diagnosed with deadly glioblastoma will receive immunotherapy with the drug ipilimumab before undergoing standard treatment, when their immune system is at its strongest. The trial, from University College London Hospital's National Hospital for Neurology and Neurosurgery, follows a previous one on the same drug which closed because of lack of recruitment. One patient from that trial, Ben Trotman, is still showing no signs of glioblastoma following the treatment – well over two years since he got the drug in a world first. Most people with glioblastoma die within 12-18 months. Mr Trotman was diagnosed with glioblastoma in October 2022, when he was 40. Now aged 43 and two years and eight months on from having the treatment, his scans are clear and there are no signs of tumour. Consultant medical oncologist, Dr Paul Mulholland, who is leading the new trial and treated Mr Trotman, said: 'It is very unusual to have a clear scan with glioblastoma, especially when he didn't have the follow-up surgery that had been planned to remove all of the tumour that was initially visible on scans. 'We hope that the immunotherapy and follow-up treatment Ben has had will hold his tumour at bay – and it has so far, which we are delighted to see.' Mr Trotman got married to Emily two months after the immunotherapy treatment and in April, his daughter Mabel was born. Mrs Trotman said: 'Getting this diagnosis was the most traumatic experience. We were grappling with the fact that Ben had gone from being apparently perfectly healthy to having months to live. 'Had we not met Dr Mulholland, that would have been it for us. We felt we had a lucky break in an otherwise devastating situation.' Mr Trotman went on to have the current standard treatment of radiotherapy and chemotherapy. He has quarterly scans, which continue to be clear. Mr Trotman said: 'We obviously don't know what the future holds but having had the immunotherapy treatment and getting these encouraging scan results has given Emily and I a bit of hope. 'We are focused on rebuilding the life we thought we had lost and enjoying being parents.' Dame Siobhain McDonagh MP led a fundraising campaign to raise more than £1 million to cover the costs of the new trial. Her sister, Baroness McDonagh, died from glioblastoma in 2023. Dame Siobhain said: 'My beloved sister Margaret was appalled to discover that there had been no advances in brain cancer treatment for decades when she was diagnosed with glioblastoma. 'Changing this was Margaret's final campaign and one that I have continued in her memory. 'I am so grateful to the many people who knew and respected Margaret who have come together and helped to raise funds and campaign for this new trial that we are calling Margaret's Trial.' Dr Paul Mulholland said: 'When I met Margaret she said to me 'what can I do to support you to cure this disease?'. 'I am incredibly grateful to her and to Siobhain whose campaigning and fundraising in her sister's memory has led to this new clinical trial opening for patients with this most aggressive form of brain cancer that has such a poor prognosis, with most patients surviving just nine months after diagnosis. 'The crucial element of this trial is that patients will have their immune system boosted by the drug before they have any other treatment, when they are fit and well enough to tolerate the immunotherapy. 'We're taking everything we have learned from previous trials into this new study and we are already planning follow-on trials. 'My aim is to find a cure for glioblastoma.' The National Brain Appeal is currently funding two posts in support of Dr Mulholland's research. Treatment will take place at the NIHR UCLH's Clinical Research Facility and at the National Hospital for Neurology and Neurosurgery. Patients interested in the new Win-Glio trial should discuss it with their consultant.

Almost half of people do not think 10-year plan will boost GP access
Almost half of people do not think 10-year plan will boost GP access

Glasgow Times

time19 minutes ago

  • Glasgow Times

Almost half of people do not think 10-year plan will boost GP access

More than four in 10 also believe the 10-year plan will make no difference or will not improve waiting times in A&E. However, there is huge support for some of the ideas included in the blueprint, with the overwhelming majority backing the creation of neighbourhood health centres, the expansion of the NHS app and more mental health support in schools and colleges. The 10-year health plan was unveiled by Prime Minister Sir Keir Starmer earlier this month, and set out a series of shifts to bring care much closer to people's homes, reducing the reliance on hospitals and A&E. Key reforms include an enhanced NHS app, giving patients more control over their care, new neighbourhood health centres open six days a week and at least 12 hours a day, and new laws on food and alcohol to prevent ill health. A survey of 1,023 adults in Britain, conducted by Ipsos for the PA news agency, asked people how they think the plan will impact access to healthcare, such as getting a GP appointment, A&E waiting times and waiting times for routine hospital treatment. Some 35% said the plan will have no impact on getting a GP appointment, while 14% believe it will make things harder. This compares with the 29% of people who said they think it will make getting an appointment easier. More than a third (37%) said it will make no difference to waiting times in emergency departments, while almost one in 10 (9%), said they believe it could worsen waiting times, compared with 30% who said it will improve them. Meanwhile, 31% said the plan will have no impact on waiting times for hospital treatment, 11% believe the plan will worsen waiting times and 34% said they think the measures will help. However, a number of proposals outlined in the plan were strongly backed by the public. Some 84% said they supported the creation of a single patient record, while 78% backed the creation of neighbourhood health centres, 73% support the expansion of the NHS app and 72% are in favour of more mental health support in schools and colleges. However, more than a quarter (27%) of people do not support making hospitals fully AI enabled, compared with 44% who would back the move. Almost one in five (18%) said they would not support so-called 'patient power payments', which would allow patients to hold back some of the payment for their care if they are not satisfied, while 42% would support the measure. Some proposals aimed at helping people to lead healthier lives were also strongly supported. A ban on the sale of high-caffeine energy drinks was backed by 78% of people, while 69% back plans to restrict junk food advertising. However, almost one in five (18%) tended to disagree with measures that could see alcoholic drinks labelled with nutritional information, although 57% backed the move. One in four people think the measures included in the plan will make no difference to patients, the poll found. Almost one in 10 (9%) said they think the changes will make things worse, while 35% believe it will improve the health service. A similar proportion, 23%, said the 10-year health plan will make no difference to NHS staff, while 13% said it could make things worse and 33% believe it will have a positive effect. A Department of Health and Social Care spokesperson said: 'We're getting on with the job of delivering for patients, with NHS waiting lists falling by 260,000 since July 2024, delivering more than 4.6 million additional appointments since the general election and recruiting over 1,900 extra GPs to fix the front door of the NHS. 'Backed by an additional £29 billion, our 10-year health plan will seize the opportunities provided by new technology, medicines and innovation to deliver better care for all patients, no matter where they live or how much they earn, and better value for taxpayers. 'It is no surprise the plan is popular with patients, it was the result of the biggest conversation with staff, patients and the public since the formation of the NHS, with more than a quarter of a million contributions.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store